TONIX Pharmaceuticals Reports Analysis of Phase 2a Study of Very Low Dosage Cyclobenzaprine in Fibromyalgia Syndrome (FMS) - Drugs.com MedNews
Links shared publicly online about this topic.
- 739total visits
TONIX Pharmaceuticals Reports Analysis of Phase 2a Study of Very Low Dosage Cyclobenzaprine in Fibromyalgia Syndrome (FMS) - Drugs.com MedNews
For the First Time, Correlation Demonstrated between Sleep Stability and Reductions of Fatigue In FMS - Results Presented at the American College of Rheumatolog
View full resource at drugs.com
Tags: Sleep, Fibromyalgia, Disease and Condition, Drug, Pharma, Muscle Relaxer, Flexeril
Most Recently Shared on November 9, 2010 at 3:21 pm By:
TONIX Pharmaceuticals Reports Analysis of Phase 2a Study of Very Low Dosage Cyclobenzaprine in Fibromyalgi... http://bit.ly/bBELqX #drug
Advertisement
